Literature DB >> 34319532

Triangulation of multiple meaningful change thresholds for patient-reported outcome scores.

Andrew Trigg1, Philip Griffiths2.   

Abstract

PURPOSE: The notion of what constitutes meaningful differences or changes in patient-reported outcome scores is represented by meaningful change thresholds (MCTs). Applying multiple methods to estimate MCTs inevitably results in a range of estimates; however, a single estimate or small range is sought in practice to enable consistent interpretation of scores. While current recommendations for triangulation are appropriate in principle, the vital step of moving from all estimates to a value or small range lacks clarity and is subjective in nature. This article aims to review current triangulation approaches and provide more robust recommendations than what is currently available.
METHODS: Current approaches to perform triangulation are described and discussed. Anchor-based estimates are focussed upon due to their recognition as the most valid and developed approach. Recommendations for triangulation are provided.
RESULTS: A correlation-weighted average of MCT estimates is recommended to triangulate multiple MCT estimates derived from a single study into a single value, where increased weighting is given to stronger anchor measures. The choice of method to triangulate estimates from several published studies is highly dependent on the availability of information within the publications. MCTs designed for between-group differences, within-group changes, and within-individual changes should be considered separately.
CONCLUSION: The recommendations within this article provide a reliable and transparent approach to triangulation when a single value is sought, based on meta-analytic approaches. This approach is preferable to a simple mean of estimates where all are weighted equally, or through 'eyeballing' plotted estimates which is unreliable. We encourage researchers to adopt these methods, but to remain aware of the limitations within each method and further nuances in study design that result in heterogeneity. Sensitivity analyses with a range of plausible values are encouraged; however, the recommendations provide a suitable starting value for inferences. Unresolved issues in triangulation, requiring further exploration, are highlighted.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Meaningful change; Minimal important difference; Patient-reported outcomes; Responder definition; Triangulation

Year:  2021        PMID: 34319532     DOI: 10.1007/s11136-021-02957-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  24 in total

1.  The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it?

Authors:  R D Hays; J M Woolley
Journal:  Pharmacoeconomics       Date:  2000-11       Impact factor: 4.981

2.  Determining the non-inferiority margin for patient reported outcomes.

Authors:  Christoph Gerlinger; Thomas Schmelter
Journal:  Pharm Stat       Date:  2011-09-19       Impact factor: 1.894

3.  Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30.

Authors:  K Cocks; M T King; G Velikova; G de Castro; M Martyn St-James; P M Fayers; J M Brown
Journal:  Eur J Cancer       Date:  2012-03-12       Impact factor: 9.162

4.  Approaches and recommendations for estimating minimally important differences for health-related quality of life measures.

Authors:  Ron D Hays; Sepideh S Farivar; Honghu Liu
Journal:  COPD       Date:  2005-03       Impact factor: 2.409

5.  Baseline dependency of minimal clinically important improvement.

Authors:  Ying-Chih Wang; Dennis L Hart; Paul W Stratford; Jerome E Mioduski
Journal:  Phys Ther       Date:  2011-03-03

6.  Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management?

Authors:  Madeleine T King; Amylou C Dueck; Dennis A Revicki
Journal:  Med Care       Date:  2019-05       Impact factor: 2.983

7.  Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma.

Authors:  Jammbe Z Musoro; Andrew Bottomley; Corneel Coens; Alexander Mm Eggermont; Madeleine T King; Kim Cocks; Mirjam Ag Sprangers; Mogens Groenvold; Galina Velikova; Hans-Henning Flechtner; Yvonne Brandberg
Journal:  Eur J Cancer       Date:  2018-10-22       Impact factor: 9.162

8.  Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach.

Authors:  Henrica C W de Vet; Raymond W J G Ostelo; Caroline B Terwee; Nicole van der Roer; Dirk L Knol; Heleen Beckerman; Maarten Boers; Lex M Bouter
Journal:  Qual Life Res       Date:  2006-10-11       Impact factor: 4.147

9.  Evaluating minimal important differences and responder definitions for the asthma symptom diary in patients with moderate to severe asthma.

Authors:  Gary Globe; Ingela Wiklund; Maria Mattera; Hao Zhang; Dennis A Revicki
Journal:  J Patient Rep Outcomes       Date:  2019-04-03

10.  Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer.

Authors:  Jammbe Z Musoro; Corneel Coens; Frederic Fiteni; Pogoda Katarzyna; Fatima Cardoso; Nicola S Russell; Madeleine T King; Kim Cocks; Mirjam Ag Sprangers; Mogens Groenvold; Galina Velikova; Hans-Henning Flechtner; Andrew Bottomley
Journal:  JNCI Cancer Spectr       Date:  2019-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.